The ABCD of obesity: an EASO position statement on a diagnostic term with clinical and scientific implications
Lower blood sugar levels are connected to decreased activity of the rate-limiting enzyme in glycogenolysis, known as hepatic glycogen phosphorylase (GP), as well as a decrease in the mRNA expression levels of key enzyme genes related to gluconeogenesis, including glucose-6-phosphatase (G6Pase), fructose-1,6-bisphosphatase (FBPase), pyruvate carboxylase (PC), and phosphoenolpyruvate carboxykinase (PEPCK)
Who This Is For The direct answer is that this is for anyone using a GLP-1 medication who has noticed changes in their skin loose skin around the jaw, crepiness on the arms, a loss of plumpness in the cheeks, or general dullness and dehydration that wasnt there before
Without adequate copper delivery to these enzymes, collagen forms but does not properly crosslink, producing weaker tissue